What is the recommended antibiotic therapy for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Therapy for Cellulitis

For non-purulent cellulitis, a 5-6 day course of antibiotics active against streptococci is recommended as first-line therapy, with coverage for MRSA considered in patients who don't respond to beta-lactam therapy or have risk factors for MRSA infection. 1, 2

First-Line Treatment Options

Non-Purulent Cellulitis (No Drainage/Exudate/Abscess)

  • First choice: Beta-lactam antibiotics targeting beta-hemolytic streptococci 1, 2
    • Amoxicillin-clavulanate
    • Cephalexin
    • Penicillin

When MRSA Coverage Is Needed

Consider MRSA coverage in patients who:

  • Do not respond to beta-lactam therapy
  • Have systemic toxicity
  • Have risk factors for MRSA (prior MRSA infection, MRSA colonization, injection drug use)
  • Have penetrating trauma

MRSA Coverage Options

  • Clindamycin 600mg orally three times daily 1, 2
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 1
  • Doxycycline or minocycline (not for children <8 years) 1, 2
  • Linezolid 600mg twice daily 1

Combination Therapy Options

When coverage for both beta-hemolytic streptococci and MRSA is desired:

  • Clindamycin alone 1, 2
  • TMP-SMX plus a beta-lactam (e.g., amoxicillin) 1, 2
  • Doxycycline plus a beta-lactam 2
  • Linezolid alone 1

Treatment Duration

  • 5-6 days for uncomplicated cellulitis 1, 2
  • Consider extending if infection hasn't improved after 5 days 2
  • Multiple studies show 5-day courses are as effective as 10-day courses 3

Hospitalized Patients with Complicated SSTI

For patients requiring hospitalization:

  • IV vancomycin 1
  • IV/oral linezolid 600mg twice daily 1
  • Daptomycin 4mg/kg/day IV 1, 4
  • Telavancin 10mg/kg/day IV 1
  • IV clindamycin 600mg three times daily 1

Special Considerations

Pediatric Patients

  • Mupirocin 2% topical ointment for minor skin infections 1
  • Avoid tetracyclines in children <8 years 1, 2
  • For hospitalized children with complicated SSTI, vancomycin is recommended 1
  • Clindamycin 10-13mg/kg/dose IV every 6-8h is an option if local resistance is low 1

Adjunctive Therapy

  • Consider systemic corticosteroids in select adult patients to hasten resolution (contraindicated in diabetics and pregnant women) 2
  • Reduce underlying edema through elevation and compression stockings 2

Prevention of Recurrent Infections

  • Keep draining wounds covered with clean, dry bandages 1
  • Maintain good personal hygiene 1
  • Avoid reusing or sharing personal items 1
  • Consider environmental hygiene measures for recurrent SSTI 1
  • Identify and treat predisposing conditions (edema, obesity, eczema, venous insufficiency) 2

Common Pitfalls to Avoid

  1. Using TMP-SMX alone for non-purulent cellulitis (poor activity against streptococci) 2
  2. Using tetracyclines in children under 8 years 1, 2
  3. Failing to obtain cultures from abscesses and purulent drainage 1
  4. Not considering MRSA coverage when risk factors are present 2
  5. Using unnecessarily prolonged antibiotic courses when shorter durations are equally effective 1, 3

The evidence strongly supports a 5-6 day course of antibiotics for uncomplicated cellulitis, with the specific choice guided by local resistance patterns and patient-specific factors such as MRSA risk. Early recognition of treatment failure and appropriate adjustment of therapy are essential to improve outcomes and reduce complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cellulitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.